1. Clinical characteristics and predictors of mortality in patients with candidemia: a six-year retrospective study.
- Author
-
Jia X, Li C, Cao J, Wu X, and Zhang L
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Anti-Bacterial Agents therapeutic use, Antifungal Agents therapeutic use, Candida drug effects, Candidemia drug therapy, Candidemia prevention & control, China epidemiology, Critical Illness epidemiology, Female, Fluconazole therapeutic use, Humans, Incidence, Intensive Care Units statistics & numerical data, Male, Microbial Sensitivity Tests, Middle Aged, Retrospective Studies, Risk Factors, Young Adult, Candida isolation & purification, Candidemia epidemiology, Candidemia mortality, Predictive Value of Tests
- Abstract
Although candidemia has been reported globally, little is known about the differences in candidemia episodes between ICU and surgical wards or the correlation between serum biomarkers and mortality from candidemia. A retrospective study of hospitalized patients with candidemia was conducted in southwest China. A total of 198 non-duplicate candidemia episodes were identified between January 2011 and December 2016. Candida albicans was the leading species causing candidemia (34.9%), and 78.8% of these isolates were susceptible to fluconazole. More than half of candidemic patients were hospitalized in surgical wards, but the incidence of these surgical patients was much lower than that of ICU patients. Compared with surgical patients, patients admitted to ICU were more frequently subjected to extensive invasive procedures, severe clinical presentations, and heavy exposure to antibiotics. In addition, the mortality in ICU was significantly higher than that in surgical wards. Multivariable analysis revealed that ascites, catheter-related candidemia, ICU admission, septic shock, and concomitant bacterial infection were independent factors associated with mortality. Moreover, we observed that high PCT and BDG levels as well as low PLT counts were also associated with mortality from candidemia. Better understanding of the specific predictors in different wards could facilitate the identification of high-risk candidates to receive early antifungal therapy, thus improving the outcomes of critically ill patients with candidemia.
- Published
- 2018
- Full Text
- View/download PDF